Meningococcal conjugate vaccines

Author： Zimmer Shanta M Stephens David S

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.4, 2004-04, pp. : 855-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of meningococcal group C conjugate vaccines

By Rüggeberg Jens Heath Paul T

Expert Opinion on Drug Safety, Vol. 2, Iss. 1, 2003-01 ,pp. : 7-19

Informa Healthcare

Access to resources Recommend Favorite

Meningococcal Vaccines

By Jens U. Rüggeberg

Pediatric Drugs, Vol. 6, Iss. 4, 2004-01 ,pp. : 251-266

Adis International

Access to resources Recommend Favorite

Meningococcal Vaccines

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 2009-2014

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccines: Hyperhaemolysis (first reports with meningococcal vaccine groups A C Y W-135 polysaccharide and Hib vaccine conjugate) in an EBV-infected patient: case report

Reactions Weekly, Vol. 1, Iss. 1278, 2009-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

New therapies and vaccines for meningococcal disease

By Carrol Enitan D Thomson Alistair PJ Hart C Anthony

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1487-1500

Informa Healthcare

Access to resources Recommend Favorite